ID

28373

Descrizione

This trial will enroll approximately 6,000 patients with recent embolic stroke of unknown source (ESUS). Patients will be randomized to dabigatran or acetylsalicyclic acid (ASA) (1:1 ratio) and have visits every three months. The study doctor may prescribe blinded concomitant ASA for pts with coronary artery disease but this is not mandatory. All Adverse Events (AEs), Serious Adverse Events (SAEs), outcome events will be recorded. The trial will conclude when the required number of stroke events are positively adjudicated which is estimated to take 3 years (including 2.5 years of enrollment). Sponsor / Information provided by (Responsible Party): Boehringer Ingelheim. https://clinicaltrials.gov/ct2/show/NCT02239120?term=NCT02239120&cond=NCT02239120&rank=1

collegamento

https://clinicaltrials.gov/ct2/show/NCT02239120?term=NCT02239120&cond=NCT02239120&rank=1

Keywords

versioni (1)
  1. 08/01/18 08/01/18 -
Titolare del copyright

Boehringer Ingelheim

Caricato su

8 gennaio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

Inglese

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

1 moduli  
Inclusion criteria
Descrizione

Inclusion criteria

Ischemic stroke with a brain lesion visualized by neuroimaging (either brain Computed Tomography (CT) or Magnetic Resonance Image (MRI))
Descrizione

The visualized stroke is a non-lacunar infarct , e.g. involving the cortex or >1.5 cm (>2.0 cm if measured on MRI diffusion-weighted images) in largest diameter if exclusively subcortical.Visualization by CT usually requires delayed imaging >24-48 hours after stroke onset.

Tipo di dati

boolean

The index stroke must have occurred either up to 3 months before randomization (Modified Rankin Scale(mRS) <=3 at randomization) or up to 6 months before randomization (mRS <=3 at randomization) in selected patients that are >= 60 years plus at least one additional risk factor for recurrent stroke
Descrizione

stroke time of occurence

Tipo di dati

boolean

Arterial imaging or cervical plus TCD ultrasonography does not show extra-cranial or intracranial atherosclerosis with >= 50% luminal stenosis in artery supplying the area of acute ischemia
Descrizione

atherosclerosis

Tipo di dati

boolean

As evidenced by cardiac monitoring for >= 20 hours with automated rhythm detection, there is absence of AF > 6 minutes in duration
Descrizione

(within a 20 hour period, either as single episode or cumulative time of multiple episodes)

Tipo di dati

boolean

Exclusion criteria
Descrizione

Exclusion criteria

Modified Rankin Scale of >=4 at time of randomization or inability to swallow medications
Descrizione

Modified Rankin Scale

Tipo di dati

boolean

Major risk cardioembolic source of embolism .
Descrizione

such as: a) intracardiac thrombus as evidenced by transthoracic or transesophageal echocardiography, b) paroxysmal, persistent or permanent AF, c) atrial flutter, d) prosthetic cardiac valve (mitral or aortic, bioprosthetic or mechanical), e) atrial myxoma, f) other cardiac tumors, g) moderate or severe mitral stenosis, h) recent (< 4weeks) myocardial infarction, i) valvular vegetations, or j) infective endocarditis

Tipo di dati

boolean

Any indication that requires treatment with an anticoagulant as per Investigator`s judgment
Descrizione

anticoagulant

Tipo di dati

boolean

History of atrial fibrillation (unless it was due to reversible causes such as hyperthyroidism or binge drinking, and has been permanently resolved)
Descrizione

History of atrial fibrillation

Tipo di dati

boolean

Other specific stroke etiology
Descrizione

i.e. cerebral arteritis or arterial dissection, migraine with aura/vasospasm, drug abuse

Tipo di dati

boolean

Renal impairment
Descrizione

Renal impairment with estimated creatinine clearance (as calculated by Cockcroft-Gault equation) <30mL/min at screening, or where Investigator expects creatinine clearance is likely to drop below 30mL/min during the course of the study

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion criteria
Ischemic stroke
Item
Ischemic stroke with a brain lesion visualized by neuroimaging (either brain Computed Tomography (CT) or Magnetic Resonance Image (MRI))
boolean
stroke time of occurence
Item
The index stroke must have occurred either up to 3 months before randomization (Modified Rankin Scale(mRS) <=3 at randomization) or up to 6 months before randomization (mRS <=3 at randomization) in selected patients that are >= 60 years plus at least one additional risk factor for recurrent stroke
boolean
atherosclerosis
Item
Arterial imaging or cervical plus TCD ultrasonography does not show extra-cranial or intracranial atherosclerosis with >= 50% luminal stenosis in artery supplying the area of acute ischemia
boolean
absence of atrial fibrillation
Item
As evidenced by cardiac monitoring for >= 20 hours with automated rhythm detection, there is absence of AF > 6 minutes in duration
boolean
Item Group
Exclusion criteria
Modified Rankin Scale
Item
Modified Rankin Scale of >=4 at time of randomization or inability to swallow medications
boolean
embolism
Item
Major risk cardioembolic source of embolism .
boolean
anticoagulant
Item
Any indication that requires treatment with an anticoagulant as per Investigator`s judgment
boolean
History of atrial fibrillation
Item
History of atrial fibrillation (unless it was due to reversible causes such as hyperthyroidism or binge drinking, and has been permanently resolved)
boolean
Other specific stroke etiology
Item
Other specific stroke etiology
boolean
Renal impairment
Item
Renal impairment
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial